KANGMEI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.99 CNY | -1.97% |
|
+4.74% | +6.99% |
| 12:10pm | Kangmei Pharmaceutical Logs Profit in Q1 | MT |
| 04-29 | Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
ETFs positioned on Kangmei Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 2,808 M€ | +6.09% | - | |
| 0.00% | 441 M€ | +5.00% | - | |
| 0.00% | 149 M€ | +3.21% | - |
Kangmei Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products intended primarily for treating hypertension and colds. The group offers Chinese medications (ginseng, salvia, codonopsis, etc.) and chemical medications (clarithromycin, doxazosin mesylate, paracetamol, etc.).
All sales are earned in China.
Sector
Pharmaceuticals
Calendar
08/05/2024
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +6.99% | 3.89B | |
| +33.29% | 664B | |
| +29.29% | 567B | |
| -7.48% | 354B | |
| +18.67% | 330B | |
| +4.55% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.86% | 148B |
- Stock Market
- Equities
- 600518 Stock
- Funds and ETFs Kangmei Pharmaceutical Co., Ltd.
